Reduced-intensity allogeneic stem cell transplantation is an effective salvage treatment for relapsed non-Hodgkin and Hodgkin's lymphomas

被引：0
|
作者：
Corradini, P
Dodero, A
Bregni, M
Olivieri, A
Valagussa, P
Farina, L
Milani, R
Scime, R
Rambaldi, A
Bonifazi, F
Patriarca, F
Locasciulli, A
Bacigalupo, A
Gianni, A
Tarella, C
机构：
[1] Ist Nazl Tumori, I-20133 Milan, Italy
[2] Ist San Raffaele, Milan, Italy
[3] Univ Ancona, Ancona, Italy
[4] Opsed Cervello, Palermo, Italy
[5] Osped Riuniti Bergamo, I-24100 Bergamo, Italy
[6] Osped St Orsola, Bologna, Italy
[7] Univ Udine, I-33100 Udine, Italy
[8] Osped San Camillo, Rome, Italy
[9] Osped San Martino Genova, Genoa, Italy
[10] Univ Turin, Turin, Italy
来源：
BONE MARROW TRANSPLANTATION | 2006年 / 37卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S47 / S47
页数：1
相关论文
共 50 条
  • [21] Reduced-Intensity Compared to Nonmyeloablative Conditioning in Patients with Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
    Nath, Karthik
    Peterson, Kristen
    Brown, Samantha
    Devlin, Sean
    Rodriguez, Natasia
    Barker, Juliet
    Giralt, Sergio
    Gyurkocza, Boglarka
    Jakubowski, Ann
    Papadopoulos, Esperanza
    Ponce, Doris
    Scordo, Michael
    Shah, Gunjan
    Perales, Miguel-Angel
    Sauter, Craig
    Lin, Andrew
    Dahi, Parastoo B.
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (01): : 81 - 92
  • [22] Stem Cell Transplantation in Childhood Non-Hodgkin's Lymphomas
    Okur, Fatma V.
    Krance, Robert
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2010, 5 (04) : 192 - 199
  • [23] Reduced-intensity conditioning followed by allogeneic transplantation can produce clinical and molecular remissions in relapsed non-Hodgkin's lymphoma
    Corradini, P
    Bregni, M
    Tarella, C
    Olivieri, A
    Dodero, A
    Farina, L
    Zallio, F
    Leoni, P
    Ciceri, F
    Devizzi, L
    Benedetti, F
    Pogliani, E
    Rambaldi, A
    Locasciulli, A
    Falda, M
    Santoro, A
    Scime, R
    Gianni, AM
    BONE MARROW TRANSPLANTATION, 2003, 31 : S57 - S57
  • [24] Stem Cell Transplantation in Childhood Non-Hodgkin’s Lymphomas
    Fatma V. Okur
    Robert Krance
    Current Hematologic Malignancy Reports, 2010, 5 : 192 - 199
  • [25] Gemcitabine, Fludarabine; and Melphalan for Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma
    Anderlini, Paolo
    Saliba, Rima M.
    Ledesma, Celina
    Plair, Tamera
    Alousi, Amin M.
    Hosing, Chitra M.
    Khouri, Issa F.
    Nieto, Yago
    Popat, Uday R.
    Shpall, Elizabeth J.
    Fanale, Michelle A.
    Hagemeister, Frederick B.
    Oki, Yasuhiro
    Neelapu, Saatva
    Romaguera, Jorge E.
    Younes, Anas
    Champlin, Richard E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (07) : 1333 - 1337
  • [26] Allogeneic peripheral blood stem cell transplantation after reduced-intensity conditioning in refractory or relapsed Hodgkin lymphoma
    Alvarez, I
    Sureda, A
    Caballero, D
    Urbano, A
    Ribera, J
    Canales, M
    Hernández-Boluda, J
    Arranz, R
    Bernal, T
    de la Serna, J
    Diez, JL
    Moraleda, J
    Rubio-Félix, D
    Sierra, J
    BONE MARROW TRANSPLANTATION, 2004, 33 : S13 - S14
  • [27] Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation For Relapsed/Refractory Hodgkin Lymphoma In The Brentuximab Vedotin Era
    Anderlini, Paolo
    Saliba, Rima
    Ledesma, Celina
    Chancoco, Christina M.
    Alexander, Tamera R.
    Alousi, Amin M.
    Hosing, Chitra
    Khouri, Issa F.
    Nieto, Yago
    Popat, Uday R.
    Shpall, Elizabeth J.
    Fanale, Michelle A.
    Oki, Yasuhiro
    Romaguera, Jorge E.
    Neelapu, Sattva S.
    Younes, Anas
    Champlin, Richard E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S72 - S72
  • [28] Feasibility of allogeneic hematopoietic stem cell transplantation (HSCT) with a reduced-intensity (RI) conditioning regimen for non-Hodgkin's lymphoma (NHL).
    Kusumi, E
    Tanimoto, TE
    Kami, M
    Hamaki, T
    Yuji, K
    Ueyama, J
    Miyakoshi, S
    Morinaga, S
    Kanda, Y
    Makimoto, A
    Kataoka, I
    Kim, SW
    Ohnishi, M
    Nakai, K
    Tobinai, K
    Tanosaki, R
    Mineishi, S
    Takaue, Y
    Mutou, Y
    BLOOD, 2001, 98 (11) : 377B - 377B
  • [29] Reduced intensity conditioning and allogeneic stem cell transplantation after salvage therapy integrating alemtuzumab for patients with relapsed peripheral T-cell non-Hodgkin's lymphoma
    Wulf, GG
    Hasenkamp, J
    Jung, W
    Chapuy, B
    Truemper, L
    Glass, B
    BONE MARROW TRANSPLANTATION, 2005, 36 (03) : 271 - 273
  • [30] Reduced intensity conditioning and allogeneic stem cell transplantation after salvage therapy integrating alemtuzumab for patients with relapsed peripheral T-cell non-Hodgkin's lymphoma
    G G Wulf
    J Hasenkamp
    W Jung
    B Chapuy
    L Truemper
    B Glass
    Bone Marrow Transplantation, 2005, 36 : 271 - 273
12345